Menu
Back to Journals » Breast Cancer: Targets and Therapy » Volume 11
Original Research
Primary systemic therapy in HER2-positive operable breast cancer using trastuzumab and chemotherapy: efficacy data, cardiotoxicity and long-term follow-up in 142 patients diagnosed from 2005 to 2016 at a single institution
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 7,375 | Dovepress* | 6,528+ | 1,650 | 8,178 | |
| PubMed Central* | 847 | 221 | 1,068 | ||
| Totals | 7,375 | 1,871 | 9,246 | ||
| *Since 27 December 2018 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar